Sarepta Therapeutics Inc (SRPT)
71.13
+1.91 (+2.76%)
USD |
NASDAQ |
May 20, 16:00
71.11
-0.02 (-0.03%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Quarterly): 856.89M for March 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2022 | 856.89M |
December 31, 2021 | 928.01M |
September 30, 2021 | 469.53M |
June 30, 2021 | 485.11M |
March 31, 2021 | 535.44M |
December 31, 2020 | 761.76M |
September 30, 2020 | 892.05M |
June 30, 2020 | 1.043B |
March 31, 2020 | 1.145B |
December 31, 2019 | 818.19M |
September 30, 2019 | 995.20M |
June 30, 2019 | 1.099B |
March 31, 2019 | 1.349B |
December 31, 2018 | 1.032B |
September 30, 2018 | 639.85M |
June 30, 2018 | 699.05M |
March 31, 2018 | 776.76M |
December 31, 2017 | 789.22M |
September 30, 2017 | 697.16M |
June 30, 2017 | 377.77M |
March 31, 2017 | 429.14M |
December 31, 2016 | 336.69M |
September 30, 2016 | 408.62M |
June 30, 2016 | 121.46M |
March 31, 2016 | 138.96M |
Date | Value |
---|---|
December 31, 2015 | 190.35M |
September 30, 2015 | 123.24M |
June 30, 2015 | 165.38M |
March 31, 2015 | 200.76M |
December 31, 2014 | 247.65M |
September 30, 2014 | 286.20M |
June 30, 2014 | 299.92M |
March 31, 2014 | 228.96M |
December 31, 2013 | 247.19M |
September 30, 2013 | 246.98M |
June 30, 2013 | 88.82M |
March 31, 2013 | 87.28M |
December 31, 2012 | 123.68M |
September 30, 2012 | -4.566M |
June 30, 2012 | 22.50M |
March 31, 2012 | 14.02M |
December 31, 2011 | 31.02M |
September 30, 2011 | 31.75M |
June 30, 2011 | 35.15M |
March 31, 2011 | 0.92M |
December 31, 2010 | -2.817M |
September 30, 2010 | 4.163M |
June 30, 2010 | 8.441M |
March 31, 2010 | 23.47M |
December 31, 2009 | 23.63M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
377.77M
Minimum
Jun 2017
1.349B
Maximum
Mar 2019
819.48M
Average
803.70M
Median
Shareholders Equity (Quarterly) Benchmarks
Alnylam Pharmaceuticals Inc | 401.17M |
Editas Medicine Inc | 512.76M |
Johnson & Johnson | 74.71B |
Geron Corp | 97.49M |
Nektar Therapeutics | 607.89M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.056B |
Total Liabilities (Quarterly) | 2.199B |
Debt to Equity Ratio | 1.282 |
Current Ratio | 5.563 |
Net Debt Paydown Yield | -0.31% |